✦ LIBER ✦

PMH3 OVERCOMING THE CHALLENGES OF MODELLING SCHIZOPHRENIA: A UK CASE STUDY OF THE COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION VS. RISPERIDONE LONG-ACTING INJECTION

✍ Scribed by SM Carroll; N Jemiai; J Moller; D Novick

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH21 COST-EFFECTIVENESS OF OLANZAPINE L

✍ H Ascher-Svanum; NM Furiak; RW Klein; W Montgomery; LJ Smolen; AH Lawson; RR Con 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

P.3.c.055 Effectiveness of long-acting i

✍ H. Kim; J. Hong 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

PMH23 A Cost-Effectiveness Analysis of t

✍ T.R. Einarson; H. Pudas; R. Zilbershtein; R. Jensen; A.T. Nielsen; C. Piwko; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

P.3.a.015 Study of the efficacy and safe

✍ Y. Inoue; H. Suzuki; M. Ootomo; S. Takeda; Y. Kawaguchi; K. Gen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

PMH28 Using Cost-Effectiveness Analysis

✍ A. Valencia-Mendoza; A. Hernández-Garduño 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB